Sinovac says its COVID-19 vaccine more effective with longer dosing interval

China’s Sinovac Biotech said on Monday that a clinical trial in Brazil showed its COVID-19 vaccine was almost 20 percentage points more effective in a small sub-group of patients who received their two doses longer apart.

Read the full article here

Related Articles